Role of Osteopontin and CD44s Expression for Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation or Resection

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 3182-3184

  Beckebaum, S ^a   Chen, X ^a   Sotiropoulos, G C ^a   Radtke, A ^a   Daoudaki, M ^a   Baba, H A ^a   Wohlschlaeger, J ^a   Broelsch, C E ^a   Gerken, G ^a   Cicinnati, V R ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; OSTEOPONTIN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD44; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; YOUNG ADULT;

EID: 55749104882     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.034     Document Type: Article

References (16)

1. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74
2. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907
3. Rittling S.R., and Chambers A.F. Role of osteopontin in tumour progression. Br J Cancer 90 (2004) 1877
4. Kim J., Ki S.S., Lee S.D., et al. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. Am J Gastroenterol 101 (2006) 2051
5. Ye Q.H., Qin L.X., Forgues M., et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9 (2003) 416
6. Furger K.A., Menon R.K., Tuck A.B., et al. The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 1 (2001) 621
7. Goodison S., Urquidi V., and Tarin D. CD44 cell adhesion molecules. Mol Pathol 52 (1999) 189
8. Giulietti A., Overbergh L., Valckx D., et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25 (2001) 386
9. Gotoh M., Sakamoto M., Kanetaka K., et al. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 52 (2002) 19
10. Takafuji V., Forgues M., Unsworth E., et al. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene 26 (2007) 6361
11. Teramoto H., Castellone M.D., Malek R.L., et al. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene 24 (2005) 489
12. Weber G.F., Ashkar S., and Cantor H. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians 109 (1997) 1
13. Gao C., Guo H., Downey L., et al. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis 24 (2003) 1871
14. Endo K., and Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol 32 (2000) 78
15. Terris B., Laurent-Puig P., Belghitti J., et al. Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinomas in France. Int J Cancer 74 (1997) 614
16. Mathew J., Hines J.E., Obafunwa J.O., et al. CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol 179 (1996) 74